🇺🇸 FDA
Pipeline program

naltrexone for extended release injectable suspension

RIH VIVITROL -01

Approved small_molecule completed

Quick answer

naltrexone for extended release injectable suspension for Substance-Related Disorders is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Substance-Related Disorders
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials